The Impact of Race in Male Breast Cancer Treatment and Outcome in the United States: A Population-Based Analysis of 4,279 Patients
Open Access
- 2 October 2014
- journal article
- research article
- Published by Hindawi Limited in International Journal of Breast Cancer
- Vol. 2014, 1-14
- https://doi.org/10.1155/2014/685842
Abstract
The purpose of this study is to compare the racial differences in treatment and overall survival (OS) of male breast cancer (MBC) patients. Data were extracted from the NCI SEER database that included population-based registries from 1988 to 2010 and analyzed using SPSS 20.0. 4,279 MBC patients were identified. 3,266 (76.3%) patients were White, 552 (12.9%) Black, 246 (5.7%) Hispanic, and 215 (5.0%) Asian. Black patients were more likely to be diagnosed at younger age , have advanced stage disease , and be unmarried and less likely to undergo lymph node dissection . When stratified by stage, there was no difference in receipt of primary treatment by race. The 5-year OS for White, Black, Hispanic, and Asian races was 73.8%, 66.3%, 74.0%, and 85.3% . This significant worse 5-year OS for Blacks persisted regardless of age, stage II or III disease, and grade 2 or 3 disease. On multivariate analysis, Black race was a significant independent prognostic factor for worse OS. Blacks were less likely to receive lymph node dissection of which patients may derive benefit, though we did not observe receipt of primary treatment, after stratifying for disease stage, to be an underlying factor contributing to racial outcome differences.This publication has 40 references indexed in Scilit:
- Male Breast Cancer: A Population-Based Comparison With Female Breast CancerJournal of Clinical Oncology, 2010
- Triple-negative breast cancers are increased in black women regardless of age or body mass indexBreast Cancer Research, 2009
- Prospective Evaluation of Risk Factors for Male Breast CancerJNCI Journal of the National Cancer Institute, 2008
- The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress?British Journal of Cancer, 2008
- Breast Cancer Risk Among Male BRCA1 and BRCA2 Mutation CarriersJNCI Journal of the National Cancer Institute, 2007
- Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotypeCancer, 2007
- Breast carcinoma in menCancer, 2004
- Is Male Breast Cancer Similar or Different than Female Breast Cancer?Breast Cancer Research and Treatment, 2004
- Racial/ethnic differences in survival rates in a population‐based series of men with breast carcinoma†Cancer, 2002
- Male breast cancer: Results of the treatments and prognostic factors in 397 casesEuropean Journal of Cancer, 1995